Manufacturers Life Insurance Company, The Pacira Bio Sciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 22,730 shares of PCRX stock, worth $533,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,730
Previous 16,922
34.32%
Holding current value
$533,700
Previous $318,000
77.36%
% of portfolio
0.0%
Previous 0.0%
Shares
35 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$123 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$53.2 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$52.6 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$48.1 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.08B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...